The Surfaxin technology! Although the market is relatively small for the liquid form that will be manufactured for the indication of RDS in infants, the market for Surfaxin LS ( the powder version) is considerably larger. Another important point is the storage factor, Surfaxin LS is freeze dried and stored as a powder until it is needed. It is then reconstituted with distilled water. This is a major advantage over Surfaxin and the animal surfactants. Looking forward to the CC this morning, which should provide alot of information regarding the future of this promising technology platform.